Enrique Hernandez, MD (@ehernzmd) 's Twitter Profile
Enrique Hernandez, MD

@ehernzmd

Gyn Oncologist, J Robert Willson Professor ObGyn @TempleMedSchool @TempleHealth. Editor-in-Chief European J Gyn Oncology @EJGO_1980 (posts are my own)

ID: 1400084190444417027

calendar_today02-06-2021 13:38:49

520 Tweet

116 Takipçi

62 Takip Edilen

EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: Diagnostic hysteroscopy doesn’t raise peritoneal cytology risk or worsen endometrial cancer prognosis. 🏠Affiliation:University of Miami 📚Read more:ejgo.net/articles/10.22… #EndometrialCancer #Hysteroscopy #WomensHealth

🩺Study: Diagnostic hysteroscopy doesn’t raise peritoneal cytology risk or worsen endometrial cancer prognosis. 
🏠Affiliation:<a href="/univmiami/">University of Miami</a> 
📚Read more:ejgo.net/articles/10.22…
 #EndometrialCancer #Hysteroscopy #WomensHealth
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Carcinosarcoma incidence & mortality rise with 3.4% & 3.2% APC. 5-yr survival at 34.9%. 📚Read more:ejgo.net/articles/10.22… #CancerResearch #Carcinosarcoma #WomensHealth

🩺Carcinosarcoma incidence &amp; mortality rise with 3.4% &amp; 3.2% APC. 5-yr survival at 34.9%.
📚Read more:ejgo.net/articles/10.22…
#CancerResearch #Carcinosarcoma #WomensHealth
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: Surgical type doesn’t impact BOT outcomes, but rupture & positive cytology raise recurrence risk. Monitor closely! 🏠Affiliation:Korea University College of Medicine 📚Read more:ejgo.net/articles/10.22… #OvarianCancer #WomensHealth #Surgery

🩺Study: Surgical type doesn’t impact BOT outcomes, but rupture &amp; positive cytology raise recurrence risk. Monitor closely! 
🏠Affiliation:<a href="/MedSchool_KU/">Korea University College of Medicine</a> 
📚Read more:ejgo.net/articles/10.22…
 #OvarianCancer #WomensHealth #Surgery
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: Sufentanil curbs endometrial cancer cell growth & invasion by blocking PI3K/Akt/mTOR pathway. 📚Read more:ejgo.net/articles/10.22… #EndometrialCancer #Oncology #Research

🩺Study: Sufentanil curbs endometrial cancer cell growth &amp; invasion by blocking PI3K/Akt/mTOR pathway. 
📚Read more:ejgo.net/articles/10.22…
 #EndometrialCancer #Oncology #Research
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: GDF15 drives endometrial cancer growth via TGF-β/Smad2/Smad3. Knocking it down shows promise! 📚Read more:ejgo.net/articles/10.22… #EndometrialCancer #Oncology #Research

🩺Study: GDF15 drives endometrial cancer growth via TGF-β/Smad2/Smad3. Knocking it down shows promise!
📚Read more:ejgo.net/articles/10.22…
#EndometrialCancer #Oncology #Research
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: 95% of Brenner tumors benign, rare malign cases need similar epithelial cancer care. More research needed! 📚Read more:ejgo.net/articles/10.22… #OvarianCancer #RareDiseases #Oncology

🩺Study: 95% of Brenner tumors benign, rare malign cases need similar epithelial cancer care. More research needed! 
📚Read more:ejgo.net/articles/10.22…
#OvarianCancer #RareDiseases #Oncology
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: PDS & NACT/IDS show similar survival in ov#surgery how similar survival in ovarian cancer, but no residual tumor boosts OS. Key finding! 🏠Affiliation:Hacettepe Üniversitesi 📚Read more:ejgo.net/articles/10.22… #OvarianCancer #Oncology #Surgery

🩺Study: PDS &amp; NACT/IDS show similar survival in ov#surgery how similar survival in ovarian cancer, but no residual tumor boosts OS. Key finding! 
🏠Affiliation:<a href="/Hacettepe1967/">Hacettepe Üniversitesi</a> 
📚Read more:ejgo.net/articles/10.22…
#OvarianCancer #Oncology #Surgery
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: Epirubicin + docetaxel boosts cervical cancer control to 74%, cuts adverse effects to 6.5%! 📚Read more:ejgo.net/articles/10.22… #CervicalCancer #Oncology #Research

🩺Study: Epirubicin + docetaxel boosts cervical cancer control to 74%, cuts adverse effects to 6.5%!
📚Read more:ejgo.net/articles/10.22…
#CervicalCancer #Oncology #Research
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: p16 & Ki-67 dual staining boosts cervical cancer screening accuracy to 89.7% sensitivity! 📚Read more:ejgo.net/articles/10.22… #CervicalCancer #Screening #WomensHealth

🩺Study: p16 &amp; Ki-67 dual staining boosts cervical cancer screening accuracy to 89.7% sensitivity!
📚Read more:ejgo.net/articles/10.22…
#CervicalCancer #Screening #WomensHealth
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: Neoadjuvant therapy matches PDS survival in stage IVB endometrial cancer, surgery key! 🏠Affiliation:The University of Tennessee Health Science Center 📚Read more:ejgo.net/articles/10.22… #WomensHealth #Oncology #Research

🩺Study: Neoadjuvant therapy matches PDS survival in stage IVB endometrial cancer, surgery key! 
🏠Affiliation:<a href="/uthsc/">The University of Tennessee Health Science Center</a> 
📚Read more:ejgo.net/articles/10.22…
#WomensHealth #Oncology #Research
EJGO (@ejgo_1980) 's Twitter Profile Photo

🩺Study: Internal iliac lymph nodes key first station in cervical cancer LNM, full removal vital! 📚Read more:ejgo.net/articles/10.22… #CervicalCancer #Oncology #Research

🩺Study: Internal iliac lymph nodes key first station in cervical cancer LNM, full removal vital!
📚Read more:ejgo.net/articles/10.22…
#CervicalCancer #Oncology #Research
Enrique Hernandez, MD (@ehernzmd) 's Twitter Profile Photo

Useful summary of adjuvant treatment of endometrial cancer in EJGO Aligning the treatment of endometrial cancer to FIGO stage based on European and American guidelines ejgo.net/articles/10.22… Temple Health Lewis Katz School of Medicine Fox Chase Cancer Center Fox Chase Surgical Oncology #Cancer #gyn

EJGO (@ejgo_1980) 's Twitter Profile Photo

🎯ZNF671 curbs #EndometrialCancer growth & stemness via Wnt/β-catenin! New target. 🔬 #ZNF671 #CancerTherapy 📚Read more:ejgo.net/articles/10.22…

🎯ZNF671 curbs #EndometrialCancer growth &amp; stemness via Wnt/β-catenin! New target. 🔬 #ZNF671 #CancerTherapy
📚Read more:ejgo.net/articles/10.22…
EJGO (@ejgo_1980) 's Twitter Profile Photo

🚨40% of HPV 16/18+ women with normal/ASCUS smears hide HSIL on biopsy! 🔬 #HPV1618 #CervicalScreening 📚Read more:ejgo.net/articles/10.22…

🚨40% of HPV 16/18+ women with normal/ASCUS smears hide HSIL on biopsy! 🔬 #HPV1618 #CervicalScreening
📚Read more:ejgo.net/articles/10.22…